Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2024
MEDYCOR from Sint-Jans-Molenbeek, company number BE0877177235, closed financial year 2024 with a result of € 263,399 after tax. For that financial year MEDYCOR recorded a gross margin of € 563,599 and equity of € 579,212. Compared with financial year 2023, the result moved from € 158,605 to € 263,399. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 15, 2025.
€ 579,212
▲ 31% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 263,399
▲ 66% vs 2023
Profit after tax over the fiscal year.
€ 19,308
▲ 145% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 126,370 paid out
48 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
3.1
Average over the fiscal year, from the social balance sheet.
€ 185,159
▲ 10% vs 2023
€ 59,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,362
▼ 19% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 350,051
▼ 15% vs 2023
€ 94,660 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 77,098
▼ 46% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 104,336
▲ 101% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 382,602 | € 413,069 | € 444,755 | € 563,599 | ▲ 27% |
| Profit after taxes | € 137,272 | € 125,170 | € 158,605 | € 263,399 | ▲ 66% |
| Equity | € 158,408 | € 283,578 | € 442,183 | € 579,212 | ▲ 31% |
| Total debts | € 716,071 | € 651,910 | € 607,960 | € 654,572 | ▲ 8% |
| Cash | € 16,328 | € 3,675 | € 7,897 | € 19,308 | ▲ 145% |
| Land & buildings | € 475,397 | € 451,774 | € 428,151 | € 404,527 | ▼ 6% |
| Retained profit | € 146,008 | € 271,178 | € 429,783 | € 566,812 | ▲ 32% |
| Dividend | € 120,000 | € 0 | € 0 | € 126,370 | |
| Bank debt | € 541,522 | € 497,995 | € 410,124 | € 350,051 | ▼ 15% |
| Balance sheet total | € 874,479 | € 935,488 | € 1,050,143 | € 1,233,783 | ▲ 17% |
| Employees (FTE) | - | 2.9 | 3.1 | 3.1 |
Key figures of MEDYCOR, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to MEDYCOR?
What happened at MEDYCOR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2024. filed late Source: NBB ↗
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
- New establishment in Sint-Jans-Molenbeek. KBO
In short
From € 137,272 profit in 2021 to € 263,399 profit in 2024.
Paid € 226,199 in corporate taxes since 2021.
Best year ever: 2024, with € 263,399 profit.
On average € 181,800 of value added per employee in 2024.
A new publication or filing at MEDYCOR? We notify you, reason included.
Follow MEDYCORDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MEDYCOR is OMAR CHAMARIQ. It owns 50% of INVEST LEOPOLD II itself.
Directors
According to the 2024 annual accounts
Establishments
Establishment units
Physical locations of this company
Leopold II laan 157
1080 Sint-Jans-Molenbeek
d'Aumalestraat 76
1070 Anderlecht
Active since 2 January 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0877.177.235
- VAT number
- BE 0877.177.235
- Registered office
- Leopold II laan 157, 1080 Sint-Jans-Molenbeek
- Names & denominations
- MEDYCOR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 November 2005
- Peppol
- Active · Active since 21 Dec 2025
- Activities · NACE
Activiteiten van huisartspraktijken
Medische praktijken
Activiteiten van medisch specialisten